These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39175619)

  • 1. A quest for stakeholder synchronization in the CAR T-cell therapy supply chain.
    Holland SM; Sohal A; Nand AA; Hutmacher DW
    Front Bioeng Biotechnol; 2024; 12():1413688. PubMed ID: 39175619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An industry survey of implementation strategies for clinical supply chain management of cell and gene therapies.
    Myles L; Church TD
    Cytotherapy; 2022 Mar; 24(3):344-355. PubMed ID: 34750073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies.
    Nikiforow S; Frigault MJ; Frey NV; Gardner RA; Komanduri KV; Perales MA; Kebriaei P; Warkentin PI; Pasquini M; Aho JL; Levine BL; Heslop HE; Hlucky TL; Habucky K; Gharibo M; Jagasia M; Locke FL
    Transplant Cell Ther; 2023 Apr; 29(4):228-239. PubMed ID: 36709800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between centralized and decentralized supply chains of autologous chimeric antigen receptor T-cell therapies: a UK case study based on discrete event simulation.
    Lam C; Meinert E; Yang A; Cui Z
    Cytotherapy; 2021 May; 23(5):433-451. PubMed ID: 33674239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teleoperator-Robot-Human Interaction in Manufacturing: Perspectives from Industry, Robot Manufacturers, and Researchers.
    Kim S; Hernandez I; Nussbaum MA; Lim S
    IISE Trans Occup Ergon Hum Factors; 2024; 12(1-2):28-40. PubMed ID: 38328969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stakeholder discussion to reduce population-wide sodium intake and decrease sodium in the food supply: a conference report from the American Heart Association Sodium Conference 2013 Planning Group.
    Antman EM; Appel LJ; Balentine D; Johnson RK; Steffen LM; Miller EA; Pappas A; Stitzel KF; Vafiadis DK; Whitsel L
    Circulation; 2014 Jun; 129(25):e660-79. PubMed ID: 24799511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the veterinary antibiotics supply chain to address antimicrobial resistance in Lao PDR: Roles and interactions of involved stakeholders.
    Poupaud M; Putthana V; Patriarchi A; Caro D; Agunos A; Tansakul N; Goutard FL
    Acta Trop; 2021 Aug; 220():105943. PubMed ID: 33965370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies.
    Wang K; Liu Y; Li J; Wang B; Bishop R; White C; Das A; Levine AD; Ho L; Levine BL; Fesnak AD
    Cytotherapy; 2019 Oct; 21(10):1081-1093. PubMed ID: 31445816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of the Scale of Third-Party Logistics Guaranteeing Firms on Bank Credit Willingness in Supply Chain Finance: An ERP Study.
    Wang X; Zhao J; Zhang H; Tang X
    Front Psychol; 2022; 13():853888. PubMed ID: 35496193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioprocessing automation in cell therapy manufacturing: Outcomes of special interest group automation workshop.
    Ball O; Robinson S; Bure K; Brindley DA; Mccall D
    Cytotherapy; 2018 Apr; 20(4):592-599. PubMed ID: 29452894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stakeholder perspectives on the challenges surrounding management and supply of essential medicines.
    Duong MH; Moles RJ; Chaar B; Chen TF
    Int J Clin Pharm; 2019 Oct; 41(5):1210-1219. PubMed ID: 31444686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstacles to global implementation of CAR T cell therapy in myeloma and lymphoma.
    Medina-Olivares FJ; Gómez-De León A; Ghosh N
    Front Oncol; 2024; 14():1397613. PubMed ID: 39099684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantages of 3PLs as healthcare supply chain orchestrators.
    Bian W; Yang X; Li S; Yang X; Hua G
    Comput Ind Eng; 2021 Nov; 161():107628. PubMed ID: 34545266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leveraging electronic logistics management information systems to enhance and optimize supply chain response during public health emergencies: lessons from COVID-19 response in Uganda.
    Wasswa JH; Oundo H; Oteba MO; Komakech H; Ochola I; Mwebaze S; Okidi D; Kirunda A; Nakadde S; Oteba NO; Lugada E
    J Pharm Policy Pract; 2023 Jan; 16(1):6. PubMed ID: 36650571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Agriculture and Food Supply Chain through Blockchain and IoT with Light Weight Cluster Head.
    Adow AH; Shrivas MK; Mahdi HF; Zahra MMA; Verma D; Doohan NV; Jalali A
    Comput Intell Neurosci; 2022; 2022():1296993. PubMed ID: 35990137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fear of Missing Out: Constrained Trial of Blockchain in Supply Chain.
    Kromes R; Li T; Bouillon M; Güler TE; van der Hulst V; Erkin Z
    Sensors (Basel); 2024 Feb; 24(3):. PubMed ID: 38339703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The growing role of biologics and biosimilars in the United States: Perspectives from the APhA Biologics and Biosimilars Stakeholder Conference.
    Crespi-Lofton J; Skelton JB
    J Am Pharm Assoc (2003); 2017; 57(5):e15-e27. PubMed ID: 28689708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stakeholder Perspectives on the Current and Future of Additive Manufacturing in Healthcare.
    Villapún VM; Carter LN; Avery S; González-Álvarez A; Andrews JW; Cox S
    Int J Bioprint; 2022; 8(3):586. PubMed ID: 36105128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparing newborn screening for the future: a collaborative stakeholder engagement exploring challenges and opportunities to modernizing the newborn screening system.
    Andrews SM; Porter KA; Bailey DB; Peay HL
    BMC Pediatr; 2022 Feb; 22(1):90. PubMed ID: 35151296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.